Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACZ885 in Patients With Type 2 Diabetes
type: MedicalStudy
description: A Multi Center, Randomized, Double Blind, Placebo-controlled, Dose Escalation Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACZ885 Administered Intravenously to Patients With Type 2 Diabetes Mellitus
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE2
start date: 2007-12
end date: 2010-09
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00605475
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Novartis
study subject: Type 2 Diabetes Mellitus
keywords: PHASE2
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Type 2 Diabetes Mellitus

AI Analytics
type: Organization